Showing results (1-10 of 28) with videos related to
Sort By:
Pageof 3
Annals of Clinical and Laboratory Science|May 1, 1988
Protein analysis with bicinchoninic acidZ K Shihabi, R D DyerJournal of Immunopharmacology|January 1, 1982
Suppression of murine T-cell mitogenesis by metabolic products of arachidonic acidK R McLeish, R D Dyer, D SenitzerBiochemistry|June 20, 2001
Slow-binding inhibition of human prostaglandin endoperoxide synthase-2 with darbufelone, an isoform-selective antiinflammatory di-tert-butyl phenolA R Johnson, M A Marletta, R D DyerThe Journal of Clinical Endocrinology and Metabolism|December 1, 1976
Binding of progesterone by human uterine cytosolR D Dyer, G E Sarto, A E ColásTherapeutic Drug Monitoring|January 1, 1989
Evaluation of an enzyme immunochromatography method for carbamazepine: a comparison with enzyme-multiplied immunoassay technique, fluorescence polarization immunoassay, and high-performance liquid chromatographyK S Oles, J K Penry, R D DyerAmerican Journal of Obstetrics and Gynecology|November 1, 1978
Synthetic progestins: in vitro potency on human endometrium and specific binding to cytosol receptorS S Shapiro, R D Dyer, A E ColásThe Journal of Biological Chemistry|November 7, 1999
Catalytic activities and substrate specificity of the human membrane type 4 matrix metalloproteinase catalytic domainY Wang, A R Johnson, Q Z Ye, et al.Archives of Biochemistry and Biophysics|December 1, 1995
Purification and characterization of prostaglandin H synthase-2 from sheep placental cotyledonsJ L Johnson, J Wimsatt, S D Buckel, et al.Journal of Medicinal Chemistry|October 2, 1992
Novel 1,2,4-oxadiazoles and 1,2,4-thiadiazoles as dual 5-lipoxygenase and cyclooxygenase inhibitorsP C Unangst, G P Shrum, D T Connor, et al.Journal of Pharmaceutical Sciences|March 1, 1994
Quantitative structure-activity relationships of 5-lipoxygenase inhibitors. Inhibitory potency of pyridazinone analoguesK H Kim, Y C Martin, D W Brooks, et al.Pageof 3